Clinical Trial Update: Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Utidelone and Bevacizumab in non-small cell lung cancer with brain metastases. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer with Brain Metastases

Drugs mentioned

• Bevacizumab (bevacizumab)
• Utidelone (utidelone)

Snippet

Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd. | Conditions: Non-small Cell Lung Cancer Patients with Brain Metastases | Phase 2 | Status: NOT_YET_RECRUITING